accession,protein_name,gene_names,length,annotation_score
O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)",PIK3CD,1044,5.0
O00444,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak),PLK4 SAK STK18,970,5.0
O00506,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),STK25 SOK1 YSK1,426,5.0
O00746,"Nucleoside diphosphate kinase D, mitochondrial (NDPK-D) (EC 2.7.4.6) (Nucleoside diphosphate kinase 4) (NDK4) (nm23-H4)",NME4 NM23D,187,5.0
O14757,Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1),CHEK1 CHK1,476,5.0
O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),CHUK IKKA TCF16,745,5.0
O60307,Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1),MAST3 KIAA0561,1309,5.0
O75191,Xylulose kinase (Xylulokinase) (EC 2.7.1.17),XYLB,536,5.0
O76039,Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9),CDKL5 STK9,960,5.0
O94768,Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2),STK17B DRAK2,372,5.0
O95544,NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase),NADK,446,5.0
O95835,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),LATS1 WARTS,1130,5.0
P00519,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),ABL1 ABL JTK7,1130,5.0
P04626,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),ERBB2 HER2 MLN19 NEU NGL,1255,5.0
P08922,Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase),ROS1 MCF3 ROS,2347,5.0
P09769,Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr),FGR SRC2,529,5.0
P10721,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117),KIT SCFR,976,5.0
P11801,Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1),PSKH1,424,5.0
P16234,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a),PDGFRA PDGFR2 RHEPDGFRA,1089,5.0
P16591,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),FER TYK3,822,5.0
P17252,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),PRKCA PKCA PRKACA,672,5.0
P17540,"Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK)",CKMT2,419,5.0
P19367,Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A),HK1,917,5.0
P20794,Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase),MAK,623,5.0
P21127,Cyclin-dependent kinase 11B (EC 2.7.11.22) (EC 2.7.11.23) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),CDK11B CDC2L1 CDK11 PITSLREA,795,5.0
P21675,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),TAF1 BA2R CCG1 CCGS TAF2A,1893,5.0
P21709,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),EPHA1 EPH EPHT EPHT1,976,5.0
P21860,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),ERBB3 HER3,1342,5.0
P22455,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334),FGFR4 JTK2 TKF,802,5.0
P23458,Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1),JAK1 JAK1A JAK1B,1154,5.0
P25098,Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2),GRK2 ADRBK1 BARK BARK1,689,5.0
P27037,Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA),ACVR2A ACVR2,513,5.0
P27144,"Adenylate kinase 4, mitochondrial (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase 3-like) (GTP:AMP phosphotransferase AK4)",AK4 AK3 AK3L1,223,5.0
P32298,G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1),GRK4 GPRK2L GPRK4,578,5.0
P33981,Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT),TTK MPS1 MPS1L1,857,5.0
P36897,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),TGFBR1 ALK5 SKR4,503,5.0
P37023,Activin receptor type-1-like (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (Serine/threonine-protein kinase receptor R3) (SKR3) (TGF-B superfamily receptor type I) (TSR-I),ACVRL1 ACVRLK1 ALK1,503,5.0
P41240,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),CSK,450,5.0
P42680,Tyrosine-protein kinase Tec (EC 2.7.10.2),TEC PSCTK4,631,5.0
P42685,Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5),FRK PTK5 RAK,505,5.0
P48730,Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26),CSNK1D HCKID,415,5.0
P49137,MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1),MAPKAPK2,400,5.0
P49619,Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma),DGKG DAGK3,791,5.0
P49761,Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3),CLK3,490,5.0
P51617,Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1),IRAK1 IRAK,712,5.0
P51813,Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38),BMX,675,5.0
P51817,cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1),PRKX PKX1,358,5.0
P51956,Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3),NEK3,506,5.0
P52789,Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase),HK2,917,5.0
P55263,"Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase) (N6,N6-dimethyladenosine kinase) (EC 2.7.1.-) (N6-isopentenyladenosine kinase) (EC 2.7.1.-) (N6-methyladenosine kinase) (EC 2.7.1.-)",ADK,362,5.0
Q00537,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),CDK17 PCTAIRE2 PCTK2,523,5.0
Q01813,"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)",PFKP PFKF,784,5.0
Q01974,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",ROR2 NTRKR2,943,5.0
Q08345,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE,913,5.0
Q13043,Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)],STK4 KRS2 MST1,487,5.0
Q13177,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)],PAK2,524,5.0
Q13470,Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1),TNK1,666,5.0
Q13705,Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB),ACVR2B,512,5.0
Q13882,Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK),PTK6 BRK,451,5.0
Q13976,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),PRKG1 PRKG1B PRKGR1A PRKGR1B,671,5.0
Q14289,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),PTK2B FAK2 PYK2 RAFTK,1009,5.0
Q15120,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)",PDK3 PDHK3,406,5.0
Q15418,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),RPS6KA1 MAPKAPK1A RSK1,735,5.0
Q15746,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",MYLK MLCK MLCK1 MYLK1,1914,5.0
Q15835,Rhodopsin kinase GRK1 (RK) (EC 2.7.11.14) (G protein-coupled receptor kinase 1),GRK1 RHOK,563,5.0
Q16584,Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase),MAP3K11 MLK3 PTK1 SPRK,847,5.0
Q16659,Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK),MAPK6 ERK3 PRKM6,721,5.0
Q3LXA3,Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],TKFC DAK,575,5.0
Q5TCS8,Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2),AK9 AKD1 AKD2 C6orf199 C6orf224,1911,5.0
Q6XUX3,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496),DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P,929,5.0
Q8IU85,Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK),CAMK1D CAMKID,385,5.0
Q8IVW4,Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE),CDKL3 NKIAMRE,592,5.0
Q8IWQ3,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12,736,5.0
Q8TBX8,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma),PIP4K2C PIP5K2C,421,5.0
Q92630,Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1),DYRK2,601,5.0
Q96GD4,Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B),AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5,344,5.0
Q96QP1,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),ALPK1 KIAA1527 LAK,1244,5.0
Q96S38,Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein),RPS6KC1 RPK118,1066,5.0
Q99759,Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3),MAP3K3 MAPKKK3 MEKK3,626,5.0
Q9BVS4,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),RIOK2 RIO2,552,5.0
Q9BZL6,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),PRKD2 PKD2 HSPC187,878,5.0
Q9H0K1,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),SIK2 KIAA0781 QIK SNF1LK2,926,5.0
Q9H2K8,Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3),TAOK3 DPK JIK KDS MAP3K18,898,5.0
Q9NWZ5,Uridine-cytidine kinase-like 1 (EC 2.7.1.48),UCKL1 URKL1 F538,548,5.0
Q9NYA1,Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-),SPHK1 SK1 SPHK SPK,384,5.0
Q9NYV4,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",CDK12 CRK7 CRKRS KIAA0904,1490,5.0
Q9UEE5,Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1),STK17A DRAK1,414,5.0
Q9UEW8,STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39),STK39 PASK SPAK,545,5.0
Q9UF33,Ephrin type-A receptor 6 (EC 2.7.10.1) (EPH homology kinase 2) (EHK-2) (EPH-like kinase 12) (EK12),EPHA6 EHK2 HEK12,1036,5.0
Q9UIJ7,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",AK3 AK3L1 AK6 AKL3L,227,5.0
Q9UQ88,Cyclin-dependent kinase 11A (EC 2.7.11.22) (EC 2.7.11.23) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2),CDK11A CDC2L2 CDC2L3 PITSLREB,783,5.0
Q9UQB9,Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C),AURKC AIE2 AIK3 AIRK3 ARK3 STK13,309,5.0
Q9Y223,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)],GNE GLCNE IBM2,722,5.0
Q9Y2K2,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),SIK3 KIAA0999 QSK L19,1321,5.0
Q9Y3S1,Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43),WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13,2297,5.0
Q9Y4B6,DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein),DCAF1 KIAA0800 RIP VPRBP,1507,5.0
Q9Y6M4,Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1),CSNK1G3,447,5.0
Q9Y6R4,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1,1608,5.0
O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),PIK3C2B,1634,5.0
O00764,Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase),PDXK C21orf124 C21orf97 PKH PNK PRED79,312,5.0
O14578,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),CIT CRIK KIAA0949 STK21,2027,5.0
O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK-2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1),IKBKB IKKB,756,5.0
O14936,Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog),CASK LIN2,926,5.0
O15021,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),MAST4 KIAA0303,2623,5.0
O15530,3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1),PDPK1 PDK1,556,5.0
O43283,Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK),MAP3K13 LZK,966,5.0
O43353,Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2),RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092,540,5.0
O75676,Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB),RPS6KA4 MSK2,772,5.0
O75747,Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PI3K-C2-gamma) (PtdIns-3-kinase C2 subunit gamma) (EC 2.7.1.137) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-gamma),PIK3C2G,1486,5.0
O94804,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),STK10 LOK,968,5.0
O94806,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),PRKD3 EPK2 PRKCN,890,5.0
O94921,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),CDK14 KIAA0834 PFTK1,469,5.0
O96013,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),PAK4 KIAA1142,591,5.0
P04629,High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA),NTRK1 MTC TRK TRKA,796,5.0
P06732,Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK),CKM CKMM,381,5.0
P07332,Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes),FES FPS,822,5.0
P08237,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)",PFKM PFKX,780,5.0
P10398,Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks),ARAF ARAF1 PKS PKS2,606,5.0
P11274,Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26),BCR BCR1 D22S11,1271,5.0
P11362,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331),FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR,822,5.0
P12532,"Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)",CKMT1A CKMT; CKMT1B CKMT,417,5.0
P14616,Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain],INSRR IRR,1297,5.0
P15056,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),BRAF BRAF1 RAFB1,766,5.0
P15531,Nucleoside diphosphate kinase A (NDP kinase A) (NDPK A) (EC 2.7.4.6) (Farnesyl diphosphate kinase NME1) (EC 2.7.4.18) (Histidine protein kinase NME1) (EC 2.7.13.3) (Metastasis inhibition factor nm23) (NM23-H1) (Non-specific serine/threonine protein kinase NME1) (EC 2.7.11.1) (Nucleoside diphoshate kinase 1) (NDK1) (Putative 3'-5'-DNA exonuclease NDK1) (EC 3.1.11.-) (Putative granzyme A-activated DNA endonuclease) (GAAD) (EC 3.1.24.-) (Tumor metastatic process-associated protein),NME1 NDPKA NM23,152,5.0
P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",PFKFB1 F6PK PFRX,471,5.0
P21802,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332),FGFR2 BEK KGFR KSAM,821,5.0
P23919,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),DTYMK CDC8 TMPK TYMK,212,5.0
P34947,G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5),GRK5 GPRK5,590,5.0
P35590,Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1),TIE1 TIE,1138,5.0
P35790,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),CHKA CHK CKI,457,5.0
P36888,Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135),FLT3 CD135 FLK2 STK1,993,5.0
P41743,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),PRKCI DXS1179E,596,5.0
P43405,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk),SYK,635,5.0
P46734,Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2),MAP2K3 MEK3 MKK3 PRKMK3 SKK2,347,5.0
P48426,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-Phosphate 4-Kinase) (PI5P4Kalpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha),PIP4K2A PI5P4KA PIP5K2 PIP5K2A,406,5.0
P50613,Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit),CDK7 CAK CAK1 CDKN7 MO15 STK1,346,5.0
P52333,Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK),JAK3,1124,5.0
P52429,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),DGKE DAGK5,567,5.0
P53779,Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3),MAPK10 JNK3 JNK3A PRKM10 SAPK1B,464,5.0
P54756,Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7),EPHA5 BSK EHK1 HEK7 TYRO4,1037,5.0
P54886,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],ALDH18A1 GSAS P5CS PYCS,795,5.0
P57059,Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK),SIK1 SIK SNF1LK,783,5.0
P78356,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta),PIP4K2B PIP5K2B,416,5.0
Q00532,Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE),CDKL1,357,5.0
Q00535,Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),CDK5 CDKN5 PSSALRE,292,5.0
Q00536,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),CDK16 PCTAIRE1 PCTK1,496,5.0
Q02156,Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon),PRKCE PKCE,737,5.0
Q02750,Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1),MAP2K1 MEK1 PRKMK1,393,5.0
Q03426,Mevalonate kinase (MK) (EC 2.7.1.36),MVK,396,5.0
Q05397,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),PTK2 FAK FAK1,1052,5.0
Q05655,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],PRKCD PKCD,676,5.0
Q06187,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),BTK AGMX1 ATK BPK,659,5.0
Q08881,Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk),ITK EMT LYK,620,5.0
Q12851,Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein),MAP4K2 GCK RAB8IP,820,5.0
Q12866,Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK),MERTK MER,999,5.0
Q13153,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),PAK1,545,5.0
Q13164,Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5),MAPK7 BMK1 ERK5 PRKM7,816,5.0
Q13188,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],STK3 KRS1 MST2,491,5.0
Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),CAMK2G CAMK CAMK-II CAMKG,558,5.0
Q15119,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",PDK2 PDHK2,407,5.0
Q15208,Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1),STK38 NDR1,465,5.0
Q16512,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),PKN1 PAK1 PKN PRK1 PRKCL1,942,5.0
Q16671,Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII),AMHR2 AMHR MISR2,573,5.0
Q16760,Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta),DGKD KIAA0145,1214,5.0
Q16774,Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1),GUK1 GMK GMPK,197,5.0
Q16854,"Deoxyguanosine kinase, mitochondrial (EC 2.7.1.113) (Deoxyadenosine kinase, mitochondrial) (EC 2.7.1.76)",DGUOK DGK,277,5.0
Q2M2I8,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),AAK1 KIAA1048,961,5.0
Q32MK0,Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK),MYLK3 MLCK,819,5.0
Q53H12,"Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase)",AGK MULK,422,5.0
Q56UN5,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",MAP3K19 RCK YSK4,1328,5.0
Q5KSL6,Diacylglycerol kinase kappa (DAG kinase kappa) (DGK-kappa) (EC 2.7.1.107) (142 kDa diacylglycerol kinase) (Diglyceride kinase kappa),DGKK,1271,5.0
Q5SY16,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9),NOL9,702,5.0
Q5TCY1,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),TTBK1 BDTK KIAA1855,1321,5.0
Q5VT25,Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha),CDC42BPA KIAA0451,1732,5.0
Q6J9G0,Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1),STYK1 NOK,422,5.0
Q6PHR2,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),ULK3,472,5.0
Q6ZMQ8,Serine/threonine-protein kinase LMTK1 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase) (AATYK) (Brain apoptosis-associated tyrosine kinase) (CDK5-binding protein) (Lemur tyrosine kinase 1) (p35-binding protein) (p35BP),AATK AATYK KIAA0641 LMR1 LMTK1,1374,5.0
Q7Z2Y5,Nik-related protein kinase (EC 2.7.11.1),NRK,1582,5.0
Q86SG6,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a),NEK8 JCK NEK12A,692,5.0
Q86TB3,Alpha-protein kinase 2 (EC 2.7.11.1) (Heart alpha-protein kinase),ALPK2 HAK,2170,5.0
Q86Y07,Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2),VRK2,508,5.0
Q86Z02,Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2),HIPK1 KIAA0630 MYAK NBAK2,1210,5.0
Q8IVS8,Glycerate kinase (EC 2.7.1.31) (HBeAg-binding protein 4),GLYCTK HBEBP4 LP5910,523,5.0
Q8IVT5,Kinase suppressor of Ras 1 (EC 2.7.11.1),KSR1 KSR,923,5.0
Q8IW41,MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK),MAPKAPK5 PRAK,473,5.0
Q8IWU2,Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2),LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2,1503,5.0
Q8IYT8,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),ULK2 KIAA0623,1036,5.0
Q8IZL9,Cyclin-dependent kinase 20 (EC 2.7.11.22) (CDK-activating kinase p42) (CAK-kinase p42) (Cell cycle-related kinase) (Cell division protein kinase 20) (Cyclin-dependent protein kinase H) (Cyclin-kinase-activating kinase p42),CDK20 CCRK CDCH,346,5.0
Q8N0W3,L-fucose kinase (Fucokinase) (EC 2.7.1.52),FCSK FUK,1084,5.0
Q8N4C8,Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6),MINK1 B55 MAP4K6 MINK YSK2 ZC3,1332,5.0
Q8N568,Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2),DCLK2 DCAMKL2 DCDC3B DCK2,766,5.0
Q8NEB9,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34),PIK3C3 VPS34,887,5.0
Q8NFU5,"Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)",IPMK IMPK,416,5.0
Q8NG66,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),NEK11,645,5.0
Q8NHU3,Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2) (SMS2),SGMS2 SMS2,365,5.0
Q92918,Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1),MAP4K1 HPK1,833,5.0
Q96C11,FGGY carbohydrate kinase domain-containing protein (D-ribulokinase FGGY) (EC 2.7.1.47),FGGY,551,5.0
Q96C45,Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4),ULK4,1275,5.0
Q96DU7,"Inositol-trisphosphate 3-kinase C (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase C) (IP3 3-kinase C) (IP3K C) (InsP 3-kinase C)",ITPKC IP3KC,683,5.0
Q96L34,MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1),MARK4 KIAA1860 MARKL1,752,5.0
Q96L96,Alpha-protein kinase 3 (EC 2.7.11.1) (Muscle alpha-protein kinase),ALPK3 KIAA1330 MAK,1705,5.0
Q96M32,Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7),AK7,723,5.0
Q96NX5,Calcium/calmodulin-dependent protein kinase type 1G (EC 2.7.11.17) (CaM kinase I gamma) (CaM kinase IG) (CaM-KI gamma) (CaMKI gamma) (CaMKIG) (CaMK-like CREB kinase III) (CLICK III),CAMK1G CLICK3 VWS1,476,5.0
Q96PF2,Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B),TSSK2 DGSG SPOGA2 STK22B,358,5.0
Q96S44,EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase),TP53RK C20orf64 PRPK,253,5.0
Q99570,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),PIK3R4 VPS15,1358,5.0
Q99683,Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5),MAP3K5 ASK1 MAPKKK5 MEKK5,1374,5.0
Q9BZX2,Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2),UCK2 UMPK,261,5.0
Q9H3Y6,Tyrosine-protein kinase Srms (EC 2.7.10.2),SRMS C20orf148,488,5.0
Q9H422,Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1),HIPK3 DYRK6 FIST3 PKY,1215,5.0
Q9HBU6,Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82),ETNK1 EKI1,452,5.0
Q9HCP0,Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1),CSNK1G1,422,5.0
Q9NRA0,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),SPHK2 SK2,654,5.0
Q9NRM7,Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase),LATS2 KPM,1088,5.0
Q9NRP7,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),STK36 KIAA1278,1315,5.0
Q9NWZ3,Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64),IRAK4,460,5.0
Q9P0L2,Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c),MARK1 KIAA1477 MARK,795,5.0
Q9P1W9,Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h),PIM2,311,5.0
Q9UBS0,Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta),RPS6KB2 STK14B,482,5.0
Q9UHJ6,Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein),SHPK CARKL,478,5.0
Q9UJ70,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase) (Muramyl dipeptide kinase) (EC 2.7.1.-) (N-acetyl-D-mannosamine kinase) (EC 2.7.1.60),NAGK,344,5.0
Q9UK32,Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4),RPS6KA6 RSK4,745,5.0
Q9UKI8,Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1),TLK1 KIAA0137,766,5.0
Q9UPE1,SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23),SRPK3 MSSK1 STK23,567,5.0
Q9UPQ8,Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15),DOLK KIAA1094 TMEM15 UNQ2422/PRO4980,538,5.0
Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17),CAMK2A CAMKA KIAA0968,478,5.0
Q9Y3D8,Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Adrenal gland protein AD-004) (Coilin-interacting nuclear ATPase protein) (hCINAP) (Dual activity adenylate kinase/ATPase) (AK/ATPase),AK6 CINAP AD-004 CGI-137,172,5.0
Q9Y6T7,Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (90 kDa diacylglycerol kinase) (Diglyceride kinase beta) (DGK-beta),DGKB DAGK2 KIAA0718,804,5.0
O00443,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),PIK3C2A,1686,5.0
O14874,"Branched-chain alpha-ketoacid dehydrogenase kinase (BCKDH kinase) (BCKDHKIN) (BDK) (EC 2.7.11.1) ([3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial) (EC 2.7.11.4)",BCKDK,412,5.0
O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],PAPSS1 ATPSK1 PAPSS,624,5.0
O60229,Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain),KALRN DUET DUO HAPIP TRAD,2986,5.0
O60331,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1gamma) (PtdIns(4)P-5-kinase 1 gamma) (EC 2.7.1.68) (Type I phosphatidylinositol 4-phosphate 5-kinase gamma),PIP5K1C KIAA0589,668,5.0
O60566,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1),BUB1B BUBR1 MAD3L SSK1,1050,5.0
O60825,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",PFKFB2,505,5.0
O75063,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase),FAM20B KIAA0475,409,5.0
O75414,"Nucleoside diphosphate kinase 6, mitochondrial (NDK6) (NDP kinase 6) (EC 2.7.4.6) (Inhibitor of p53-induced apoptosis-alpha) (IPIA-alpha) (nm23-H6)",NME6,186,5.0
O75460,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],ERN1 IRE1,977,5.0
O75716,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2) (hPSK),STK16 MPSK1 PKL12 TSF1,305,5.0
O75912,Diacylglycerol kinase iota (DAG kinase iota) (DGK-iota) (EC 2.7.1.107),DGKI,1057,5.0
O75914,Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3),PAK3 OPHN3,559,5.0
O95382,Mitogen-activated protein kinase kinase kinase 6 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 2),MAP3K6 ASK2 MAPKKK6 MEKK6,1288,5.0
P00533,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),EGFR ERBB ERBB1 HER1,1210,5.0
P04183,"Thymidine kinase, cytosolic (EC 2.7.1.21)",TK1,234,5.0
P05129,Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13),PRKCG PKCG,697,5.0
P05771,Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13),PRKCB PKCB PRKCB1,671,5.0
P06213,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],INSR,1382,5.0
P07947,Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes),YES1 YES,543,5.0
P08631,Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck),HCK,526,5.0
P09619,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b),PDGFRB PDGFR PDGFR1,1106,5.0
